145 related articles for article (PubMed ID: 12581899)
1. A novel tumorigenic human prostate epithelial cell line (M2205): molecular cytogenetic characterization demonstrates C-MYC amplification and jumping translocations.
Jackson-Cook C; Zou Y; Turner K; Astbury C; Ware J
Cancer Genet Cytogenet; 2003 Feb; 141(1):56-64. PubMed ID: 12581899
[TBL] [Abstract][Full Text] [Related]
2. Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype.
Hukku B; Mally M; Cher ML; Peehl DM; Kung H; Rhim JS
Cancer Genet Cytogenet; 2000 Jul; 120(2):117-26. PubMed ID: 10942801
[TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic analysis of a nontumorigenic human breast epithelial cell line that eventually turns tumorigenic: validation of an analytical approach combining karyotyping, comparative genomic hybridization, chromosome painting, and single-locus fluorescence in situ hybridization.
Nielsen KV; Niebuhr E; Ejlertsen B; Holstebroe S; Madsen MW; Briand P; Mouridsen HT; Bolund L
Genes Chromosomes Cancer; 1997 Sep; 20(1):30-7. PubMed ID: 9290951
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines.
Harris CP; Lu XY; Narayan G; Singh B; Murty VV; Rao PH
Genes Chromosomes Cancer; 2003 Mar; 36(3):233-41. PubMed ID: 12557223
[TBL] [Abstract][Full Text] [Related]
5. Amplification of C-MYC as the origin of the homogeneous staining region in ovarian carcinoma detected by micro-FISH.
Abeysinghe HR; Cedrone E; Tyan T; Xu J; Wang N
Cancer Genet Cytogenet; 1999 Oct; 114(2):136-43. PubMed ID: 10549271
[TBL] [Abstract][Full Text] [Related]
6. Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.
Pan Y; Kytölä S; Farnebo F; Wang N; Lui WO; Nupponen N; Isola J; Visakorpi T; Bergerheim US; Larsson C
Cytogenet Cell Genet; 1999; 87(3-4):225-32. PubMed ID: 10702678
[TBL] [Abstract][Full Text] [Related]
7. Optical genome mapping reveals balanced and unbalanced genetic changes associated with tumor-forming potential in an early-stage prostate cancer epithelial subline (M2205).
Paulraj P; Barrie E; Jackson-Cook C
Mol Genet Genomic Med; 2024 Jan; 12(1):e2307. PubMed ID: 37902189
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetically balanced translocations are associated with focal copy number alterations.
Watson SK; deLeeuw RJ; Horsman DE; Squire JA; Lam WL
Hum Genet; 2007 Feb; 120(6):795-805. PubMed ID: 17051368
[TBL] [Abstract][Full Text] [Related]
9. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.
Luk C; Tsao MS; Bayani J; Shepherd F; Squire JA
Cancer Genet Cytogenet; 2001 Mar; 125(2):87-99. PubMed ID: 11369051
[TBL] [Abstract][Full Text] [Related]
10. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer.
Reiter RE; Sato I; Thomas G; Qian J; Gu Z; Watabe T; Loda M; Jenkins RB
Genes Chromosomes Cancer; 2000 Jan; 27(1):95-103. PubMed ID: 10564591
[TBL] [Abstract][Full Text] [Related]
11. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line.
Bae VL; Jackson-Cook CK; Maygarden SJ; Plymate SR; Chen J; Ware JL
Prostate; 1998 Mar; 34(4):275-82. PubMed ID: 9496902
[TBL] [Abstract][Full Text] [Related]
12. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
Qian J; Jenkins RB; Bostwick DG
Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping.
Macville M; Schröck E; Padilla-Nash H; Keck C; Ghadimi BM; Zimonjic D; Popescu N; Ried T
Cancer Res; 1999 Jan; 59(1):141-50. PubMed ID: 9892199
[TBL] [Abstract][Full Text] [Related]
14. Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63.
Lim G; Karaskova J; Vukovic B; Bayani J; Beheshti B; Bernardini M; Squire JA; Zielenska M
Cancer Genet Cytogenet; 2004 Sep; 153(2):158-64. PubMed ID: 15350306
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15.
Jackson-Cook C; Bae V; Edelman W; Brothman A; Ware J
Cancer Genet Cytogenet; 1996 Mar; 87(1):14-23. PubMed ID: 8646734
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts.
Williams BJ; Jones E; Kozlowski JM; Vessella R; Brothman AR
Genes Chromosomes Cancer; 1997 Apr; 18(4):299-304. PubMed ID: 9087570
[TBL] [Abstract][Full Text] [Related]
17. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines.
Knutsen T; Rao VK; Ried T; Mickley L; Schneider E; Miyake K; Ghadimi BM; Padilla-Nash H; Pack S; Greenberger L; Cowan K; Dean M; Fojo T; Bates S
Genes Chromosomes Cancer; 2000 Jan; 27(1):110-6. PubMed ID: 10564593
[TBL] [Abstract][Full Text] [Related]
18. Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors.
Foukakis T; Thoppe SR; Lagercrantz S; Dwight T; Weng WH; Svensson A; Höög A; Zedenius J; Wallin G; Lui WO; Larsson C
Int J Oncol; 2005 Jan; 26(1):141-9. PubMed ID: 15586234
[TBL] [Abstract][Full Text] [Related]
19. Multiple reciprocal translocations in salivary gland mucoepidermoid carcinomas.
Tonon G; Gehlhaus KS; Yonescu R; Kaye FJ; Kirsch IR
Cancer Genet Cytogenet; 2004 Jul; 152(1):15-22. PubMed ID: 15193437
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft.
Aldosari N; Wiltshire RN; Dutra A; Schrock E; McLendon RE; Friedman HS; Bigner DD; Bigner SH
Neuro Oncol; 2002 Apr; 4(2):75-85. PubMed ID: 11916498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
